Patel, M., Peters, K., Lipp, E., Low, J., Herndon, J. I. I., Broadwater, G., … Affronti, M. (2020). OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS. In NEURO-ONCOLOGY (Vol. 22, pp. 175–175).

Patel, Mallika, Katherine Peters, Eric Lipp, Justin Low, James I. I. Herndon, Gloria Broadwater, Margaret Johnson, Dina Randazzo, Jung-Young Kim, and Mary Affronti. “OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS.” In NEURO-ONCOLOGY, 22:175–175, 2020.

Patel M, Peters K, Lipp E, Low J, Herndon JII, Broadwater G, et al. OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS. In: NEURO-ONCOLOGY. 2020. p. 175–175.

Patel, Mallika, et al. “OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS.” NEURO-ONCOLOGY, vol. 22, 2020, pp. 175–175.

Patel M, Peters K, Lipp E, Low J, Herndon JII, Broadwater G, Johnson M, Randazzo D, Kim J-Y, Affronti M. OLANZAPINE FOR REFRACTORY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS. NEURO-ONCOLOGY. 2020. p. 175–175.